Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021

We evaluated routine testing with SARS-CoV-2 Delta variant-specific RT-PCR in regional hospital laboratories in addition to centralised national genomic surveillance in the Netherlands during June and July 2021. The increase of the Delta variant detected by RT-PCR correlated well with data from geno...

Descripción completa

Detalles Bibliográficos
Autores principales: Molenkamp, Richard, Fanoy, Ewout, Derickx, Leonie, de Groot, Theun, Jonges, Marcel, Leenstra, Tjalling, Nijhuis, Roel, Pas, Suzan, Vahidnia, Ali, von Wintersdorff, Christian, Mulder, Bert, Koopmans, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511753/
https://www.ncbi.nlm.nih.gov/pubmed/34622759
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.40.2100921
Descripción
Sumario:We evaluated routine testing with SARS-CoV-2 Delta variant-specific RT-PCR in regional hospital laboratories in addition to centralised national genomic surveillance in the Netherlands during June and July 2021. The increase of the Delta variant detected by RT-PCR correlated well with data from genomic surveillance and was available ca 2 weeks earlier. This rapid identification of the relative abundance and increase of SARS-CoV-2 variants of concern may have important benefits for implementation of local public health measures.

Ejemplares similares